Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Brown, Joseph N ^a   Brewer, Heather M ^a   Nicora, Carrie D ^a   Weitz, Karl K ^a   Morris, Michael J ^b   Skabelund, Andrew J ^b   Adkins, Joshua N ^a   Smith, Richard D ^a   Cho, Ji Hoon ^c   Gelinas, Richard ^c  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Biomarkers; Dyspnea; Lavage fluid; MicroRNAs; Proteomics; Serum; Urine

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BETA DEFENSIN; FATTY ACID BINDING PROTEIN 4; HEME OXYGENASE; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; MICRORNA; MICRORNA 187 3P; MICRORNA 1915 3P; MICRORNA 212 3P; MICRORNA 371A 5P; MICRORNA 421; MICRORNA 4488; MICRORNA 4532; MICRORNA 489; MICRORNA 663A; PROTEIN; PROTEIN FETUA; PROTEIN HPT; PROTEIN K2C1; PROTEIN KV404; PROTEIN TFF3; PROTEIN TRY6; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSCRIPTOME;

ACCURACY; AFGHANISTAN; ARTICLE; ASTHMA; BLOOD; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FIBEROPTIC BRONCHOSCOPY; FORCED VITAL CAPACITY; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IRAQ; LIQUID CHROMATOGRAPHY; LUNG DIFFUSION CAPACITY; LUNG GAS EXCHANGE; LUNG LAVAGE; MILITARY DEPLOYMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RNA ANALYSIS; SOLDIER; SYMPTOM; TANDEM MASS SPECTROMETRY; UPREGULATION; URINE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; DISEASE COURSE; GENETICS; LUNG; METABOLISM; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE;

BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; DYSPNEA; HUMANS; LUNG; MICRORNAS; PRECISION MEDICINE; PROTEOMICS; TRANSCRIPTOME;

EID: 84908095285     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-58     Document Type: Article

References (55)

1. Study of active duty military for pulmonary disease related to environmental deployment exposures (STAMPEDE). Morris M, Dodson D, Lucero P, Haislip G, Gallup R, Nicholson K, Zacher L, Am J Respir Crit Care Med 2014 190 77 84 10.1164/rccm.201402-0372OC 24922562
2. Mid-region Pro-hormone markers for diagnosis and prognosis in acute DyspneaResults from the BACH (biomarkers in acute heart failure) trial. Maisel A, Mueller C, Nowak R, Peacock W, Landsberg J, Ponikowski P, Mockel M, Hogan C, Wu A, Richards M, Clopton P, Filippatos G, Di Somma S, Anand I, Ng L, Daniels L, Neath S, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler N, Anker S, J Am Coll Cardiol 2010 55 2062 2076 10.1016/j.jacc.2010.02.025 20447528
3. Asthma outcomes: biomarkers. Szefler S, Wenzel S, Brown R, Erzurum S, Fahy J, Hamilton R, Hunt J, Kita H, Liu A, Panettieri R, Schleimer R, Minnicozzi M, J Allergy Clin Immunol 2012 129 9 S23 10.1016/j.jaci.2011.12.979 22386512
4. Biomarkers in asthma: a real hope to better manage asthma. Erzurum S, Gaston B, Clin Chest Med 2012 33 459 471 10.1016/j.ccm.2012.06.007 22929095
5. Allergic asthma biomarkers using systems approaches. Sircar G, Saha B, Bhattacharya S, Saha S, Front Genet 2013 4 308 doi:10.3389/fgene.2013.00308; PMCID: PMC3884215
6. Gene expression networks in COPD: microRNA and mRNA regulation. Ezzie M, Crawford M, Cho J, Orellana R, Zhang S, Gelinas R, Batte K, Yu L, Nuovo G, Galas D, Diaz P, Wang K, Nana-Sinkam P, Thorax 2011 doi:10.1136/thoraxjnl-2011-200089
7. Serum biomarkers in COPD survivors and controls. Longitudinal analysis. Pinto-Plata V, Mullerova H, Casanova C, de Torres J, Corado H, Varo N, Cordoba E, Baz R, Cortopasi F, Divo M, Kelly E, Celli B, Am J Respir Crit Care Med 2012 185 4507
8. Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. Cho J, Gelinas R, Wang K, Etheridge A, Piper M, Batte K, Dakhlallah D, Price J, Bornman D, Zhang S, Marsh C, Galas D, BMC Med Genet 2011 4 8
9. Urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have different patterns in heart failure exacerbation. Park M, Vittinghoff E, Liu K, Shlipak M, Hsu C, Biomark Insights 2013 8 15 23531625
10. Urine stability studies for novel biomarkers of acute kidney injury. Parikh C, Butrymowicz I, Yu A, Chinchilli V, Park M, Hsu C, Reeves W, Devarajan P, Kimmel P, Siew E, Liu K, Am J Kidney Dis 2014 63 567 572 10.1053/j.ajkd.2013.09.013 24200462
11. Tumour markers in prostate cancer III: biomarkers in urine. Roobol MJ, Haese A, Bjartell A, Acta Oncol 2011 50 85 89 10.3109/0284186X.2010.524935 21604945
12. Urine biomarkers in prostate cancer. Ploussard G, de la Taille A, Nat Rev Urol 2010 7 101 109 10.1038/nrurol.2009.261 20065953
13. Urine MicroRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline. Ben-Dov I, Tan Y, Morozov P, Wilson P, Rennert H, Blumenfeld J, Tuschl T, PLoS One 2014 9 86856 10.1371/journal.pone.0086856 24489795
14. Self-made frits for nanoscale columns in proteomics. Maiolica A, Borsotti D, Rappsilber J, Proteomics 2005 5 3847 3850 10.1002/pmic.200402010 16130174
15. Chemically etched open tubular and monolithic emitters for nanoelectrospray ionization mass spectrometry. Kelly RT, Page JS, Luo Q, Moore RJ, Orton DJ, Tang K, Smith R, Anal Chem 2006 78 7796 7801 10.1021/ac061133r 17105173
16. Advances in proteomics data analysis and display using an accurate mass and time tag approach. Zimmer JS, Monroe ME, Qian WJ, Smith R, Mass Spectrom Rev 2006 25 450 482 10.1002/mas.20071 16429408
17. A statistical method for assessing Peptide identification confidence in accurate mass and time tag proteomics. Stanley JR, Adkins JN, Slysz GW, Monroe ME, Purvine SO, Karpievitch YV, Anderson GA, Smith RD, Dabney AR, Anal Chem 2011 83 6135 6140 10.1021/ac2009806 21692516
18. Decon2LS: an open-source software package for automated processing and visualization of high resolution mass spectrometry data. Jaitly N, Mayampurath A, Littlefield K, Adkins JN, Anderson GA, Smith RD, BMC Bioinform 2009 10 87 doi:10.1186/1471-2105-10-87 10.1186/1471-2105-10-87
19. VIPER: an advanced software package to support high-throughput LC-MS peptide identification. Monroe ME, Tolić N, Jaitly N, Shaw JL, Adkins JN, Smith RD, Bioinformatics 2007 23 2021 2023 Epub 2007 Jun 1 10.1093/bioinformatics/btm281 17545182
20. A statistical selection strategy for normalization procedures in LC-MS proteomics experiments through dataset-dependent ranking of normalization scaling factors. Webb-Robertson BJ, Matzke MM, Jacobs JM, Pounds JG, Waters KM, Proteomics 2011 11 4736 4741 10.1002/pmic.201100078 22038874
21. The utility of accurate mass and LC elution time information in the analysis of complex proteomes. Norbeck A, Monroe M, Adkins J, Smith R, J Am Soc Mass Spectrom 2005 16 1239 1249 10.1016/j.jasms.2005.05.009 15979333
22. Improved quality control processing of peptide-centric LC-MS proteomics data. Matzke MM, Waters KM, Metz TO, Jacobs JM, Sims AC, Baric RS, Pounds JG, Webb-Robertson BJ, Bioinformatics 2011 27 2866 2872 10.1093/bioinformatics/btr479 21852304
23. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Huang D, Sherman B, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler M, Lane H, Lempicki R, Nucleic Acids Res 2007 35 suppl 2 169 W175 17576678
24. Protein quantification in label-free LC-MS experiments. Clough T, Key M, Ott I, Ragg S, Schadow G, Vitek O, J Proteome Res 2009 8 5275 5284 10.1021/pr900610q 19891509
25. Controlling the false discovery rate-a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, j Roy Stat Soc B Met 1995 57 289 300
26. Team RDC, R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing 2008
27. Direct multiplexed measurement of gene expression with color-coded probe pairs. Geiss G, Bumgarner R, Birditt B, Dahl T, Dowidar N, Dunaway D, Fell H, Ferree S, George R, Grogan T, James J, Maysuria M, Mitton J, Oliveri P, Osborn J, Peng T, Ratcliffe A, Webster P, Davidson E, Hood L, Krassen D, Nat Biotechnol 2008 26 317 325 10.1038/nbt1385 18278033
28. The microRNA spectrum in 12 body fluids. Weber J, Baxter D, Zhang S, Huang D, Huang K, Lee M, Galas D, Wang K, Clin Chem 2010 2010 56 1733 1741 doi:10.1373/clinchem.2010.147405
29. NanoStringNorm. Waggott D, Chu K, Yin S, Wouters B, Liu F, Boutros P, Bioinformatics 2012 28 1546 1548 10.1093/bioinformatics/bts188 22513995
30. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Smyth GK, Stat Appl Genet Mol Biol 2004 3 1 Article 3
31. New-onset asthma among soldiers serving in Iraq and Afghanistan. Szema AM, Peters MC, Weissinger KM, Gagliano CA, Chen J, Allergy Asthma Proc 2010 31 67 71 doi:10.2500/aap.2010.31.3383 20929596
32. Constrictive bronchiolitis in soldiers returing from Iraq and Afghanistan. King M, Eisenberg R, Newman J, Tolle J, Harrell F, Nian H, Ninan M, Lambright E, Sheller J, Johnson J, Miller R, N Engl J Med 2011 365 222 230 doi:10.1056/NEJMoa1101388 10.1056/NEJMoa1101388 21774710
33. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Li XJ, Hayward C, Fong PY, Dominguez M, Hunsucker SW, Lee LW, McLean M, Law S, Butler H, Schirm M, Gingras O, Lamontagne J, Allard R, Chelsky D, Price ND, Lam S, Massion PP, Pass H, Rom WN, Vachani A, Fang KC, Hood L, Kearney P, Sci Transl Med 2013 5 207ra 142
34. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Fan R, Vermesh O, Srivastava A, Yen B, Qin L, Ahmad H, Kwong G, Liu C, Gould J, Hood L, Heath J, Nat Biotechnol 2008 26 1373 1378 doi:10.1038/nbt.1507 10.1038/nbt.1507 19029914
35. Pulmonary Hypertension: Pathology. Dorfmüller P, Pharmacotherapy of Pulmonary Hypertension Heidelberg: Springer Berlin 2013 59 75
36. Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale. de Prost N, Parrot A, Cuquemelle E, Picard C, Cadranel J, Lung 2013 191 559 563 10.1007/s00408-013-9491-3 23867964
37. Iron laden macrophages in idiopathic pulmonary fibrosis: the telltale of occult alveolar hemorrhage? Puxeddu E, Comandini A, Cavalli F, Pezzuto G, D'Ambrosio C, Senis L, Paci M, Curradi G, Sergiacomi G, Saltini C, Pulmonary Pharmacol Therapeutics 2014 28 35 40 10.1016/j.pupt.2013.12.002
38. miRNA-125b regulates TNF-α production in CD14+ neonatal monocytes via post-transcriptional regulation. Huang H, Yu H, Huang L, Huang HC, Chen R, Lin I, Ou C, Hsu T, Yang K, J Leukoc Biol 2012 92 171 182 10.1189/jlb.1211593 22581933
39. Asthma: mechanisms of disease persistence and progression. Cohn L, Elias J, Chupp G, Annu Rev Immunol 2004 22 789 815 10.1146/annurev.immunol.22.012703.104716 15032597
40. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. Broide DH, J Allergy Clin Immunol 2008 121 560 570 10.1016/j.jaci.2008.01.031 18328887
41. The regulation of fibrosis in airway remodeling in asthma. Royce S, Cheng V, Samuel C, Tang M, Mol Cell Endocrinol 2012 351 167 175 10.1016/j.mce.2012.01.007 22266540
42. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Pritchard C, Kroh E, Wood B, Arroyo J, Dougherty K, Miyaji M, Tait J, Tewari M, Cancer Prevention Res 2012 5 492 497 doi:10.1158/1940-6207.capr-11-0370 10.1158/1940-6207.CAPR-11-0370
43. β-catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin pathway. Zhou A, Diao L, Xu H, Xiao Z, Li J, Xhou H, Qu L, Oncogene 2012 31 2968 2978 10.1038/onc.2011.461 22020335
44. ATM is down-regulated by N-Myc-regulated microRNA-421. Hu H, Du L, Nagabayashi G, Seeger R, Gatti R, Proc Natl Acad Sci U S A 2010 107 1506 1511 10.1073/pnas.0907763107 20080624
45. MicroRNAs: new players in the DNA damage response. Hu H, Gatti R, J Mol Cell Biol 2011 3 151 158 10.1093/jmcb/mjq042 21183529
46. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C, Biochem Biophys Res Comm 2011 406 552 557 10.1016/j.bbrc.2011.02.086 21352803
47. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Zhang X, Cui L, Ye G, Zheng T, Song H, Xia T, Yu X, Xiao B, Le Y, Guo J, Tumor Biol 2012 33 2349 2355 10.1007/s13277-012-0497-x
48. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens R, Okamoto A, Yokota J, Tanaka T, Calin G, Liu C, Croce C, Harris C, Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703
49. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Van Pottelberge G, Mestdagh P, Bracke K, Thas O, van Durme Y, Joos G, Vandesompele J, Brusselle G, Am J Respir Crit Care Med 2011 183 898 906 10.1164/rccm.201002-0304OC 21037022
50. Bronchial airway microRNA expression associated with chronic obstructive pulmonary disease. Wang T, Campbell J, Liu G, LeClerc A, Alekseyev Y, Luo L, Xiao J, Zhang X, Sin D, McWilliams A, Lam S, Spira A, Lenburg M, Am J Respir Crit Care Med 2013 187 1201
51. Airway epithelial miRNA expression is altered in asthma. Solberg O, Ostrin E, Love M, Peng J, Bhakta N, Hou L, Nguyen C, Solon M, Nguyen C, Barczak A, Zlock L, Blagev D, Finkbeiner W, Ansel K, Arron J, Erle D, Woodruff P, Am J Respir Crit Care Med 2012 186 965 974 doi:10.1164/rccm.201201-00170C 10.1164/rccm.201201-0027OC 22955319
52. Tumor-associated circulating microRNAs as biomarkers of cancer. Wang J, Zhang K-Y, Liu S-M, Sen S, Molecules 2014 19 1912 1938 doi:10.3390/molecules19021912 10.3390/molecules19021912 24518808
53. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabro E, Croce C, Pastorino U, Sozzi G, Proc Natl Acad Sci U S A 2011 108 3713 3718 doi/10.1073/pnas.1100048108 10.1073/pnas.1100048108 21300873
54. Analysis of organ-enriched microRNAs in plasma as an approach to development of universal screening test: feasibility study. Sheinerman K, Tsivinsky V, Umansky S, J Transl Med 2013 11 304 doi:10.1186/1479-5876-11-304 10.1186/1479-5876-11-304 24330742
55. Performance evaluation of commercial miRNA expression array platforms. Sah S, McCall M, Eveleigh D, Wilson M, Irizarry R, BMC Res Notes 2010 3 80 doi:10.1186/1756-0500-3-80 10.1186/1756-0500-3-80 20298588